Kodaira, Japan

Shigenori Kotani


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal2 out of 832,880 
Other
 patents

Years Active: 1983-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shigenori Kotani: Innovator in Sydnonimine Compounds

Introduction

Shigenori Kotani is a notable inventor based in Kodaira, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of sydnonimine compounds. With a total of 2 patents to his name, his work focuses on innovative solutions for treating circulatory system disorders.

Latest Patents

Kotani's latest patents include the N-Acyl-3-[4-(benzoylalkyl)piperazin-1-yl]-sydnonimine compound and the process for its production. This compound is represented by a specific formula where R¹ can be a hydrogen atom or an alkyl group with 1 to 8 carbon atoms. Another significant patent involves syndonimine derivatives, which are also represented by a defined formula. These compounds are particularly useful for addressing issues related to the circulatory system and can be synthesized through a reaction involving a specific piperazine derivative.

Career Highlights

Throughout his career, Kotani has demonstrated a commitment to advancing pharmaceutical science. His innovative approaches have led to the development of compounds that hold promise for therapeutic applications. His work is characterized by a focus on practical solutions to complex medical challenges.

Collaborations

Kotani has collaborated with esteemed colleagues such as Hiroyoshi Hidaka and Ikuo Matsumoto. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Shigenori Kotani's contributions to the field of medicinal chemistry, particularly through his patents on sydnonimine compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in treatments for circulatory system disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…